The Chemours Competitors

The Chemours (NYSE:CC) and FMC (NYSE:FMC) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.

Volatility and Risk

The Chemours has a beta of 2.3, indicating that its stock price is 130% more volatile than the S&P 500. Comparatively, FMC has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.

Earnings & Valuation

This table compares The Chemours and FMC's top-line revenue, earnings per share and valuation.

FMC has lower revenue, but higher earnings than The Chemours. The Chemours is trading at a lower price-to-earnings ratio than FMC, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares The Chemours and FMC's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and target prices for The Chemours and FMC, as provided by MarketBeat.

The Chemours currently has a consensus target price of $31.3750, suggesting a potential downside of 9.61%. FMC has a consensus target price of $130.00, suggesting a potential upside of 9.78%. Given FMC's stronger consensus rating and higher possible upside, analysts clearly believe FMC is more favorable than The Chemours.

Insider & Institutional Ownership

74.7% of The Chemours shares are owned by institutional investors. Comparatively, 87.4% of FMC shares are owned by institutional investors. 2.7% of The Chemours shares are owned by insiders. Comparatively, 1.0% of FMC shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Dividends

The Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 2.9%. FMC pays an annual dividend of $1.92 per share and has a dividend yield of 1.6%. The Chemours pays out 39.8% of its earnings in the form of a dividend. FMC pays out 31.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Chemours has increased its dividend for 1 consecutive years and FMC has increased its dividend for 1 consecutive years.

Summary

FMC beats The Chemours on 11 of the 16 factors compared between the two stocks.

Olin (NYSE:OLN) and The Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership and dividends.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Olin and The Chemours, as provided by MarketBeat.

Olin currently has a consensus price target of $43.1538, suggesting a potential downside of 8.24%. The Chemours has a consensus price target of $31.3750, suggesting a potential downside of 9.61%. Given Olin's stronger consensus rating and higher probable upside, equities research analysts plainly believe Olin is more favorable than The Chemours.

Institutional & Insider Ownership

84.7% of Olin shares are held by institutional investors. Comparatively, 74.7% of The Chemours shares are held by institutional investors. 11.7% of Olin shares are held by company insiders. Comparatively, 2.7% of The Chemours shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility & Risk

Olin has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, The Chemours has a beta of 2.3, suggesting that its share price is 130% more volatile than the S&P 500.

Valuation & Earnings

This table compares Olin and The Chemours' top-line revenue, earnings per share (EPS) and valuation.

Olin has higher revenue and earnings than The Chemours. The Chemours is trading at a lower price-to-earnings ratio than Olin, indicating that it is currently the more affordable of the two stocks.

Dividends

Olin pays an annual dividend of $0.80 per share and has a dividend yield of 1.7%. The Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 2.9%. Olin pays out 133.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. The Chemours pays out 39.8% of its earnings in the form of a dividend. Olin has increased its dividend for 1 consecutive years and The Chemours has increased its dividend for 1 consecutive years. The Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Profitability

This table compares Olin and The Chemours' net margins, return on equity and return on assets.

Summary

Olin beats The Chemours on 9 of the 16 factors compared between the two stocks.

Huntsman (NYSE:HUN) and The Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, earnings and profitability.

Analyst Recommendations

This is a breakdown of recent ratings for Huntsman and The Chemours, as reported by MarketBeat.

Huntsman currently has a consensus target price of $30.6875, indicating a potential upside of 3.29%. The Chemours has a consensus target price of $31.3750, indicating a potential downside of 9.61%. Given Huntsman's stronger consensus rating and higher possible upside, research analysts plainly believe Huntsman is more favorable than The Chemours.

Profitability

This table compares Huntsman and The Chemours' net margins, return on equity and return on assets.

Dividends

Huntsman pays an annual dividend of $0.65 per share and has a dividend yield of 2.2%. The Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 2.9%. Huntsman pays out 42.5% of its earnings in the form of a dividend. The Chemours pays out 39.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman has increased its dividend for 1 consecutive years and The Chemours has increased its dividend for 1 consecutive years. The Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Earnings & Valuation

This table compares Huntsman and The Chemours' revenue, earnings per share (EPS) and valuation.

Huntsman has higher revenue and earnings than The Chemours. The Chemours is trading at a lower price-to-earnings ratio than Huntsman, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

77.3% of Huntsman shares are held by institutional investors. Comparatively, 74.7% of The Chemours shares are held by institutional investors. 5.4% of Huntsman shares are held by company insiders. Comparatively, 2.7% of The Chemours shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Huntsman has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Comparatively, The Chemours has a beta of 2.3, indicating that its stock price is 130% more volatile than the S&P 500.

Summary

Huntsman beats The Chemours on 9 of the 16 factors compared between the two stocks.

Ashland Global (NYSE:ASH) and The Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk and analyst recommendations.

Profitability

This table compares Ashland Global and The Chemours' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Ashland Global and The Chemours, as provided by MarketBeat.com.

Ashland Global currently has a consensus price target of $92.4444, indicating a potential upside of 3.15%. The Chemours has a consensus price target of $31.3750, indicating a potential downside of 9.61%. Given Ashland Global's stronger consensus rating and higher probable upside, analysts clearly believe Ashland Global is more favorable than The Chemours.

Earnings & Valuation

This table compares Ashland Global and The Chemours' revenue, earnings per share (EPS) and valuation.

The Chemours has higher revenue and earnings than Ashland Global. The Chemours is trading at a lower price-to-earnings ratio than Ashland Global, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

91.9% of Ashland Global shares are owned by institutional investors. Comparatively, 74.7% of The Chemours shares are owned by institutional investors. 10.1% of Ashland Global shares are owned by company insiders. Comparatively, 2.7% of The Chemours shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility & Risk

Ashland Global has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Comparatively, The Chemours has a beta of 2.3, meaning that its stock price is 130% more volatile than the S&P 500.

Dividends

Ashland Global pays an annual dividend of $1.10 per share and has a dividend yield of 1.2%. The Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 2.9%. Ashland Global pays out 39.3% of its earnings in the form of a dividend. The Chemours pays out 39.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ashland Global has raised its dividend for 1 consecutive years and The Chemours has raised its dividend for 1 consecutive years.

Summary

Ashland Global beats The Chemours on 9 of the 16 factors compared between the two stocks.

The Chemours (NYSE:CC) and Univar Solutions (NYSE:UNVR) are both mid-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends.

Profitability

This table compares The Chemours and Univar Solutions' net margins, return on equity and return on assets.

Insider and Institutional Ownership

74.7% of The Chemours shares are owned by institutional investors. Comparatively, 98.6% of Univar Solutions shares are owned by institutional investors. 2.7% of The Chemours shares are owned by company insiders. Comparatively, 1.6% of Univar Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares The Chemours and Univar Solutions' gross revenue, earnings per share (EPS) and valuation.

The Chemours has higher earnings, but lower revenue than Univar Solutions. The Chemours is trading at a lower price-to-earnings ratio than Univar Solutions, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for The Chemours and Univar Solutions, as reported by MarketBeat.

The Chemours currently has a consensus target price of $31.3750, suggesting a potential downside of 9.61%. Univar Solutions has a consensus target price of $26.75, suggesting a potential downside of 0.07%. Given Univar Solutions' higher possible upside, analysts plainly believe Univar Solutions is more favorable than The Chemours.

Risk and Volatility

The Chemours has a beta of 2.3, meaning that its stock price is 130% more volatile than the S&P 500. Comparatively, Univar Solutions has a beta of 1.98, meaning that its stock price is 98% more volatile than the S&P 500.

Summary

The Chemours beats Univar Solutions on 9 of the 14 factors compared between the two stocks.

The Chemours (NYSE:CC) and W. R. Grace & Co. (NYSE:GRA) are both mid-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

Volatility & Risk

The Chemours has a beta of 2.3, suggesting that its share price is 130% more volatile than the S&P 500. Comparatively, W. R. Grace & Co. has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500.

Profitability

This table compares The Chemours and W. R. Grace & Co.'s net margins, return on equity and return on assets.

Insider and Institutional Ownership

74.7% of The Chemours shares are owned by institutional investors. Comparatively, 84.8% of W. R. Grace & Co. shares are owned by institutional investors. 2.7% of The Chemours shares are owned by insiders. Comparatively, 0.9% of W. R. Grace & Co. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Dividends

The Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 2.9%. W. R. Grace & Co. pays an annual dividend of $1.32 per share and has a dividend yield of 1.9%. The Chemours pays out 39.8% of its earnings in the form of a dividend. W. R. Grace & Co. pays out 30.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Chemours has raised its dividend for 1 consecutive years and W. R. Grace & Co. has raised its dividend for 1 consecutive years.

Analyst Recommendations

This is a summary of current ratings and target prices for The Chemours and W. R. Grace & Co., as reported by MarketBeat.

The Chemours currently has a consensus target price of $31.3750, indicating a potential downside of 9.61%. W. R. Grace & Co. has a consensus target price of $66.8571, indicating a potential downside of 2.41%. Given W. R. Grace & Co.'s higher probable upside, analysts clearly believe W. R. Grace & Co. is more favorable than The Chemours.

Valuation and Earnings

This table compares The Chemours and W. R. Grace & Co.'s top-line revenue, earnings per share and valuation.

W. R. Grace & Co. has lower revenue, but higher earnings than The Chemours. The Chemours is trading at a lower price-to-earnings ratio than W. R. Grace & Co., indicating that it is currently the more affordable of the two stocks.

Summary

W. R. Grace & Co. beats The Chemours on 10 of the 16 factors compared between the two stocks.